HIM
ZBH icon

Hanlon Investment Management’s Zimmer Biomet ZBH Stock Holding History

Hanlon Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-40,046
Closed -$4.68M – 117
2016
Q2 		$4.68M Buy
+40,046
New +$4.53M 0.41% 73

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hanlon Investment Management's ZBH Position: Q3 2016 in Review

Hanlon Investment Management sold out of Zimmer Biomet (ZBH) in Q3 2016, closing a stake of 40,046 shares — an estimated $4.68M sold.

Hanlon Investment Management first reported a position in ZBH in Q2 2016 and held it in 1 quarter. The position peaked at $4.68M in Q2 2016. 808 funds tracked by Wall St. Rank hold ZBH as of Q3 2016.

  • Hanlon Investment Management reported no remaining Zimmer Biomet position as of Q3 2016 after selling out during the quarter.
  • Hanlon Investment Management sold 40,046 Zimmer Biomet shares in Q3 2016, an estimated $4.68M.
  • Hanlon Investment Management first reported a position in Zimmer Biomet in Q2 2016 and held it in 1 quarter.
  • Hanlon Investment Management's Zimmer Biomet position peaked at $4.68M in Q2 2016.
  • 808 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2016.

Based on Hanlon Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.